Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease. Masataka Ichikawa (Keio University, Japan) and colleagues from BiomX have shown in a new paper that oral and oral+IV administration of a phage cocktail supresses K. pneumoniae levels and attenuates PSC disease severity in mice.